Werbung
Werbung

CTSO

CTSO logo

Cytosorbents Corp.

0.68
USD
Gesponsert
0.00
+0.59%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

0.68

0.00
0.00%

CTSO Ergebnisberichte

Positives Überraschungsverhältnis

CTSO übertreffen die 21 der letzten 40Schätzungen.

53%

Nächster Bericht

Datum des nächsten Berichts
01. März 2026
Estimate for Q4 25 (Revenue/ EPS)
$9.81M
/
-$0.04
Implizierte Änderung von Q4 26 (Revenue/ EPS)
--
/
--
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+7.18%
/
-71.43%

Cytosorbents Corp. earnings per share and revenue

On 02. Jan. 2026, CTSO reported earnings of -- USD per share (EPS) for Q4 26, -- the estimate of -0.01 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 11.26 million, with a --% difference. The market reacted with a +2.60% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analysts forecast an EPS of -0.04 USD, with revenue projected to reach 9.81 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Neogen Corp
Report Date
08. Jan. 2026 For Q2 26
Estimate
$0.05
Aktuell
$0.10
Überraschung
+78.25%
logo
Tilray Brands, Inc. Common Stock
Report Date
08. Jan. 2026 For Q2 26
Estimate
-$0.20
Aktuell
-$0.41
Überraschung
-100.98%
FAQ
For Q4 2026, Cytosorbents Corp. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved up 2.6%, changed from $0.64 before the earnings release to $0.66 the day after.
The next earning report is scheduled for 01. März 2026.
Based on 5 analysts, Cytosorbents Corp. is expected to report EPS of -$0.04 and revenue of $9.81M for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung